CONNPLEX2025-04-012025-09-30CONNPLEX2025-09-30CONNPLEX2025-03-31CONNPLEX2025-04-012025-09-30in-capmkt:OtherExpenses1MemberCONNPLEX2025-04-012025-09-30in-capmkt:OtherExpenses2MemberCONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain1CONNPLEX2025-03-31RelatedPartyTransactionDomain1CONNPLEX2025-09-30RelatedPartyTransactionDomain1CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain2CONNPLEX2025-03-31RelatedPartyTransactionDomain2CONNPLEX2025-09-30RelatedPartyTransactionDomain2CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain3CONNPLEX2025-03-31RelatedPartyTransactionDomain3CONNPLEX2025-09-30RelatedPartyTransactionDomain3CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain4CONNPLEX2025-03-31RelatedPartyTransactionDomain4CONNPLEX2025-09-30RelatedPartyTransactionDomain4CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain5CONNPLEX2025-03-31RelatedPartyTransactionDomain5CONNPLEX2025-09-30RelatedPartyTransactionDomain5CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain6CONNPLEX2025-03-31RelatedPartyTransactionDomain6CONNPLEX2025-09-30RelatedPartyTransactionDomain6CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain7CONNPLEX2025-03-31RelatedPartyTransactionDomain7CONNPLEX2025-09-30RelatedPartyTransactionDomain7CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain8CONNPLEX2025-03-31RelatedPartyTransactionDomain8CONNPLEX2025-09-30RelatedPartyTransactionDomain8CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain9CONNPLEX2025-03-31RelatedPartyTransactionDomain9CONNPLEX2025-09-30RelatedPartyTransactionDomain9CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain10CONNPLEX2025-03-31RelatedPartyTransactionDomain10CONNPLEX2025-09-30RelatedPartyTransactionDomain10CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain11CONNPLEX2025-03-31RelatedPartyTransactionDomain11CONNPLEX2025-09-30RelatedPartyTransactionDomain11CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain12CONNPLEX2025-03-31RelatedPartyTransactionDomain12CONNPLEX2025-09-30RelatedPartyTransactionDomain12CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain13CONNPLEX2025-03-31RelatedPartyTransactionDomain13CONNPLEX2025-09-30RelatedPartyTransactionDomain13CONNPLEX2025-04-012025-09-30RelatedPartyTransactionDomain14CONNPLEX2025-03-31RelatedPartyTransactionDomain14CONNPLEX2025-09-30RelatedPartyTransactionDomain140000002025-09-30Statement10000002025-04-012025-09-30Statement1CONNPLEX2025-09-30StatementDynamic1I1Statement1CONNPLEX2025-09-30StatementDynamic1I2Statement1CONNPLEX2025-09-30StatementDynamic1I3Statement1CONNPLEX2025-09-30StatementDynamic1I4Statement1CONNPLEX2025-09-30StatementDynamic1I5Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares000000CONNPLEXNOTLISTEDINE0EAS01014CONNPLEX CINEMAS LIMITEDSMEEquity2025-04-012026-03-312025-11-102025-11-04INRLakhsHalf YearlyHalf yearlySingle segmentEntertainment Industry2025-11-1015:00:002025-11-1018:20:00trueCash Flow IndirectNot applicabletruetrueNANAfalsetrue2025-05-23https://theconnplex.com/true1falseNot Applicable2025-04-012025-09-30UnauditedStandalone64059900050580006456570000267320000-63565000375910007440009531000220700000472321000173336000017333600001733360004254500025300042798000130538000000130538000130538000191000000108.518.51Notes: <BR> 1. The standalone financial result for the half year ended September 30, 2025 have been prepared in accordance with the requirement of Accounting Standard (AS) prescribed under Section 133 of the Companies Act 2013 read with relevant rules thereunder and in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Company is exempted from the compulsory requirement of adoption of IND-AS. It has not adopted IND-AS for preparation of financial results. <BR> 2 The above Standalone unaudited financial result for the half year ended September 30, 2025 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on November 10, 2025 . <BR> 3. The comparative results and other information for the six months ended September 30, 2025 are not audited by the statutory auditors of the Company. The management has exercised necessary due diligence to ensure that the said comparative results provide a true and fair view of its affairs. <BR> 4. The Earning Per Share (EPS) have been computed in accordance with Accounting Standard on Earning Per Share (EPS) AS-20. The EPS for the Half year ended 30th september 2025 and 30th september2024 is not annualised. EPS for the respective periods have been calculated based on the weighted average number of shares outstanding as 30th September, 2025. <BR> 5. As Company's business activity falls within single primary business segment hence the disclosure requirement as per AS-17 "Segment Reporting" is not applicable. <BR> 6. The results for the half year ended September 30, 2025 will be available on the Stock Exchange website (www.nseindia.com) and on the Company's website(www.theconnplex.com). <BR> 7. There is no investor Complaints pending as on 30th september, 2025 <BR> 8. In the current period, the Company has completed its initial public offer ("IPO") of 51,00,000 Equity Shares of Rs. 10 each at an issue price of Rs. 177 per equity share (including security Premium Rs.167 per equity share). The issue was entirely fresh issue of Equity Shares for value aggregating to Rs.9,027.00 lakhs. Pursuant to IPO, the equity shares of the Company were listed on Emerge platform of National Stock Exchange of India Limited w.e.f. 14 August, 2025.Direct Expenses142981000Other Expenses7771900019100000010217330000121273300000177350000017194300025970001922750000088981000889810003670600045271000170958000157596600014033900007000048649000018899500076034500092600001100000570670001008433000542310001373320002255860004773200001160001025360005675330001575966000744000953100000000-4202000006073000-63565000-941680002616800026955000-411860000-145796000-139723000336130000000-42545000-893200000-893200000000000-85900071989000000000038350000-7399050000-80891800000-8089180008357080000011970000007440000-42500084650900000846509000286590000286590001906900047728000CONNPLEX CINEMAS LIMITED******ANISH TULSHIBHAI PATEL******Managing DirectorRemunerationNA3600000392000707000CONNPLEX CINEMAS LIMITED******RAHUL KAMLESHBHAI DHYANI******Joint Managing DirectorRemunerationNA360000088000244000CONNPLEX CINEMAS LIMITED******TULSHIBHAI KANJIBHAIPATEL******Relative of Managing DirectorRemunerationNA900000125000475000CONNPLEX CINEMAS LIMITED******KAMLESHBHAI JAYANTILAL DHYANI******Relative of Joint Managing DirectorRemunerationNA4500009700001420000CONNPLEX CINEMAS LIMITED******POONAM ANISH PATEL******Relative of Managing DirectorRemunerationNA60000048000647000CONNPLEX CINEMAS LIMITED******ARCHANA RAHUL DHYANI******Relative of Joint Managing DirectorRemunerationNA4500006690001118000CONNPLEX CINEMAS LIMITED******PUJAN ASHVINBHAI THAKKAR******Chief Financial OfficerRemunerationNA59400066000103000CONNPLEX CINEMAS LIMITED******RATIKA KHANDELWAL******Company SecrateryRemunerationNA960001600016000CONNPLEX CINEMAS LIMITED******PARSHWA SHAH******Independent DirectorAny other transactionDirector Sitting FeesNA70000032000CONNPLEX CINEMAS LIMITED******RONAK ASHOKBHAI MEHTA******Independent DirectorAny other transactionDirector Sitting FeesNA70000032000CONNPLEX CINEMAS LIMITED******AMISHA FENIL SHAH******Independent DirectorAny other transactionDirector Sitting FeesNA3500000CONNPLEX CINEMAS LIMITED******NILKANTH FILM FIESTA******Entity in Which Director are ParttnerPurchase of goods or servicesNA3935000248000421000CONNPLEX CINEMAS LIMITED******NILKANTH FILM FIESTA******Entity in Which Director are ParttnerSale of goods or servicesNA356500012480001190000CONNPLEX CINEMAS LIMITED******CONNPLEX SKY THEATRE PRIVATE LIMITED******Common DirectorAny other transactionAmount Receivable FromNA0160001600017965000Public Issues2025-08-129027000002025-09-30trueCARE Rating LimitedfalseThe Audit Committee and the Board of Directors have reviewed the Monitoring Agency draft Report for the half year ended September 30, 2025. The Board noted that an amount of ₹0.62 crore was utilized from the General Corporate Purpose (GCP) portion towards tax payment (specifically, payment of TDS). The Board clarified that this payment represents a routine statutory obligation to the Government of India, as the Company regularly remits TDS every month in the normal course of its business operations. Accordingly, the said payment does not constitute an issue-related expense but forms part of the Company’s regular statutory compliances.No commentAnish Tulshibhai PatelManaging DirectorAhmedabad2025-11-12Funding Capital Expenditure requirement for purchase of Corporate OfficeNot Applicable147900000000Funding Capital Expenditure requirement of purchase of LED Screens and ProjectorsNot Applicable2444000000140800000Funding Working Capital RequirementNot Applicable376300000089790000Funding General Corporate PurposeNot Applicable641000000398970000Public Issue related expensesNot Applicable700000000686030000